CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
OPERATING ACTIVITIES
Net income including noncontrolling interest	$ 1,652.4	$ 982.2
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation	473.7	463.3
Amortization	226.2	229.8
Deferred income taxes	(149.7)	(45.9)
Share-based compensation expense	109.5	73.4
Pension and postretirement plan contributions	(43.7)	(92.2)
Pension and postretirement plan expense (income), net	11.5	6.0
Restructuring charges, net of cash paid	(11.7)	(17.5)
Gain on sale of global surgical solutions business	(382.7)
Other, net	17.7	21.1
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	(109.3)	(88.9)
Inventories	(163.6)	266.4
Other assets	(41.1)	25.2
Accounts payable	277.7	(245.7)
Other liabilities	180.3	(17.9)
Cash provided by operating activities	2,047.2	1,559.3
INVESTING ACTIVITIES
Capital expenditures	(634.8)	(512.2)
Property and other assets sold	3.3	9.5
Acquisitions and investments in affiliates, net of cash acquired	(56.4)	(106.8)
Divestiture of businesses, net of cash divested	889.7
Other, net	(8.1)	(32.6)
Cash provided by (used for) investing activities	193.7	(642.1)
FINANCING ACTIVITIES
Net issuances of commercial paper and notes payable	3.3	(0.3)
Long-term debt repayments	(630.4)
Reacquired shares	(983.7)	(11.7)
Dividends paid	(502.9)	(462.6)
Exercise of employee stock options	232.8	61.2
Hedge settlements	(0.6)	(53.4)
Other, net	(2.5)	(2.4)
Cash used for financing activities	(1,884.0)	(469.2)
Effect of exchange rate changes on cash and cash equivalents	(15.3)	(45.3)
Increase in cash and cash equivalents	341.6	402.7
Cash and cash equivalents, beginning of period	919.5	598.6
Cash and cash equivalents, end of period	$ 1,261.1	$ 1,001.3